Drug intelligence / Profile preview

3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol

Development stage
Unknown
Lead developer
Pfizer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01

Overview

3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol is a synthetic small molecule belonging to the class of benzenesulfonyl compounds and sulfones. It features a butyn-yloxy group attached to a phenyl ring with a sulfonyl linkage and a terminal thiol group on the propane chain. This compound was developed as part of research into potent inhibitors of tumor necrosis factor-alpha converting enzyme (TACE), also known as ADAM17, which is involved in the cleavage of membrane-bound TNF-alpha and other substrates. The compound (notably referred to as "compound 8b" in literature) demonstrated excellent in vitro potency against TACE/ADAM17 with good selectivity over matrix metalloproteinases (MMPs), including MMP2, MMP7, MMP8, MMP9, and MMP13. Its mechanism involves binding to the catalytic site of TACE via its thiol moiety chelating the active site zinc ion. There are no approved clinical indications or marketed products containing this molecule; it remains an experimental tool compound for biochemical studies on metalloprotease inhibition[6].

Other names
3-[4-(but-2-yn-1-yloxy)benzenesulfonyl]propane-1-thiol3-{[4-(2-butyn-1-yloxy)phenyl]sulfonyl}-1-propanethiol3-(4-but-2-ynoxyphenyl)sulfonylpropane-1-thiolthiol-aryl sulfone 8b
02

Targets

MMP13 (Matrix metalloproteinase-13)MMP9 (Matrix metalloproteinase-9)MMP2 (Matrix metalloproteinase-2)ADAM17 (A disintegrin and metalloprotease 17)MMP7 (Matrix metallopeptidase 7)MMP8 (Neutrophil collagenase)

Beyond the preview

Go deeper on 3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call